Over 7,000 Antidepressants Recalled Over Potentially Cancer-Causing Chemical

The antidepressants contain levels of N-nitroso-duloxetine that are above the limit set by the U.S. Food and Drug Administration.
Over 7,000 Antidepressants Recalled Over Potentially Cancer-Causing Chemical
A patient prepares to take a pill in Kansas City, Kansas, on Oct. 12, 2022. Charlie Riedel/AP Photo
|Updated:
0:00

More than 7,000 bottles of the antidepressant duloxetine have been recalled across the United States after they were found to contain levels of a potentially cancer-causing chemical above the limit set by the U.S. Food and Drug Administration (FDA).

The recall of Duloxetine Delayed-Release Capsules—manufactured by Towa Pharmaceutical Europe—was first initiated on Oct. 10 owing to a “nitrosamine drug substance related impurity,” according to an FDA notice.
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.